13-NON Competitive CSS Fisher Scientific Vios iDx 255 L CO2 Incubator 75N98026Q00760.docx

NON-COMPETITIVE

COMBINED SYNOPSIS / SOLICITATION

Title: Purchase Order for Fisher Scientific Vios iDx 255 L CO2 Incubator.

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued.

(ii) The solicitation number is 75N98026Q00760. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable).

This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii).

The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a Purchase Order on a non-competitive basis to Fisher Scientific Company LLC, 300 Industry Drive, Pittsburgh, PA, United States for the purchase of two Fisher Scientific Vios iDx 255 L CO2 Incubators.

(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (insert current circular number and date).

(iv) The associated NAICS code is 334516 Analytical Laboratory Instrument Manufacturing. This requirement is not set aside for small business.

(v) Description of Requirement:

The National Institute of Environmental Health Sciences (NIEHS) / Division of Translational Toxicology (DTT) / Mechanistic Toxicology Branch (MTB) needs to purchase of two Thermo Scientific Vios iDx 255L CO2 incubators from Fisher Scientific Company LLC, 300 Industry Drive, Pittsburgh, PA, United States.

The incubators will support ongoing and expanding research in the culture and maintenance of various cell lines, including pluripotent stem cell lines and cancer cell lines, and for development and culture of multiple 3D organoid model systems. These incubators will also be used for high-throughput screening exposures of these cell lines and organoid models.

Requirements:

Incubators must meet the specifications listed below needed for the storage, culture and maintenance of sensitive cell lines and models and allow for homogenous growth conditions and fast recovery of all parameters, minimizing the exposure of cell cultures/organoids to fluctuations and maintaining stable conditions with rapid recovery of all parameters.

· Equivalent homogenous growth conditions and fast recovery of all parameters, and maintenance of stable conditions with rapid recovery time.

· Same culture conditions as our current Vios incubator systems. This is necessary for standardization of protocols and projects.

· Condensation-free humidification system with protected, integrated 3-L water reservoir.

· Equivalent high-temperature sterilization cycle that provides a sterility assurance level to help avoid issues with contamination that can ruin cultures and experiments

· Equivalent air quality conditions via an in-chamber HEPA filtration system.

(vi) Delivery Location:

NIH/NIEHS

111 TW Alexander Drive Research Triangle Park, NC 27709

(vii) [Reserved, if needed]

(viii) FAR 52.204-7, System for Award Management, applies to this acquisition.

(ix) The provision at FAR 52.212-1, Instructions to Offerors—Commercial Items, applies to this acquisition. Add any additional instructions as required.

(x) The provision at FAR 52.212-2, Evaluation—Commercial Items, applies to this acquisition.

(a) A written notice of award or acceptance of an offer, issued to the successful offeror within the time specified in the offer, shall result in a binding contract without further action by either party.

The Government reserves the right to accept any offer (or part of an offer) before the expiration date, whether or not discussions are conducted, unless a written notice of withdrawal is received prior to award. Add additional evaluation criteria as required.

(xi) FAR 52.212-4, Contract Terms and Conditions—Commercial Items, applies to this acquisition.

(xii) Additional contract requirements or terms and conditions, as determined necessary by the Contracting Officer and consistent with customary commercial practices: None.

(xiii) The Defense Priorities and Allocations System (DPAS) is not applicable to this requirement.

(xiv) Submission Requirements:

Responses must include sufficient information to demonstrate the respondent’s capability to provide the required product or service. Price quotations shall include, at a minimum: unit price, list price, shipping and handling costs, delivery timeframe after award, delivery terms, prompt payment discount terms, F.O.B. point (destination or origin), product or catalog numbers, product descriptions, and any other relevant information.

Evaluation factors may include, but are not limited to: past performance, technical capability, special features, trade-in considerations, expected lifecycle, warranty, maintenance availability, and environmental or energy efficiency considerations.

Respondents claiming to be manufacturers or authorized resellers of a specified brand-name product must provide:

(a) Product, catalog, model, and/or part number(s);

(b) Product description;

(c) Documentation demonstrating that the offered item meets all required salient characteristics;

(d) Quantity;

(e) Estimated price or cost;

(f) Shipping, handling, and/or installation charges; and

(g) Delivery timeframe after receipt of order.

Responses must also include the Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification. All offerors must be actively registered in the System for Award Management (SAM) at www.sam.gov.

All responses must be received by July 27, 2026 and must reference solicitation number 75N98026Q00760. Responses may be submitted electronically to wagstaff@nih.gov.

(xv) Point of Contact:

Francisca Wagstaff at wagstaff@nih.gov